| Line item | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Cost of Revenue | – | – | – | – |
| Gross Profit | – | – | – | – |
| Operating Expenses | – | – | – | – |
| R&D | $1.18M | $5.00M | $12.18M | $6.31M |
| SG&A | $264.01K | $278.81K | $478.25K | $197.13K |
| Operating Income | – | – | – | – |
| Interest Expense | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.80M | -$7.37M | -$14.96M | -$8.65M |
| EPS (basic) | -0.6500 | -1.9800 | – | – |
| EPS (diluted) | -0.6500 | -1.9800 | -1.2100 | – |
| Shares (diluted) | $4.31M | $3.72M | – | – |